JP2020513032A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020513032A5 JP2020513032A5 JP2020502532A JP2020502532A JP2020513032A5 JP 2020513032 A5 JP2020513032 A5 JP 2020513032A5 JP 2020502532 A JP2020502532 A JP 2020502532A JP 2020502532 A JP2020502532 A JP 2020502532A JP 2020513032 A5 JP2020513032 A5 JP 2020513032A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- composition
- sequestering
- metabolite
- behavioral symptoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762480039P | 2017-03-31 | 2017-03-31 | |
| US62/480,039 | 2017-03-31 | ||
| PCT/US2018/025607 WO2018183986A1 (en) | 2017-03-31 | 2018-03-31 | Gut-selective sequestering agents for the treatment and prevention of autism and related disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020513032A JP2020513032A (ja) | 2020-04-30 |
| JP2020513032A5 true JP2020513032A5 (enExample) | 2021-04-15 |
| JP6978122B2 JP6978122B2 (ja) | 2021-12-08 |
Family
ID=63677186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020502532A Expired - Fee Related JP6978122B2 (ja) | 2017-03-31 | 2018-03-31 | 自閉症および関連障害の治療および予防のための腸管選択的隔離剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US10617718B2 (enExample) |
| EP (1) | EP3600349A4 (enExample) |
| JP (1) | JP6978122B2 (enExample) |
| KR (1) | KR102328323B1 (enExample) |
| CN (2) | CN110944650B (enExample) |
| AU (3) | AU2018243836B9 (enExample) |
| BR (1) | BR112019020289A2 (enExample) |
| CA (2) | CA3191747A1 (enExample) |
| WO (1) | WO2018183986A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3600349A4 (en) | 2017-03-31 | 2020-09-30 | Axial Biotherapeutics, Inc. | SELECTIVE GUT SEQUESTRATION AGENTS FOR THE TREATMENT AND PREVENTION OF AUTISM AND RELATED DISORDERS |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| WO2021011481A1 (en) * | 2019-07-12 | 2021-01-21 | The General Hospital Corporation | Anti-inflammatory factors |
| WO2021126220A1 (en) * | 2019-12-19 | 2021-06-24 | Hill's Pet Nutrition, Inc. | Compositions and methods of treating and reducing risk of conditions associated with elevated 4-ethylphenyl sulfate in canines using tomato pomace and methods of identifying canines at risk of such conditions |
| WO2022026450A1 (en) * | 2020-07-27 | 2022-02-03 | Duke University | Assessment and treatment of depression, anxiety, or related disorders |
| CN113440522B (zh) * | 2021-07-29 | 2022-12-13 | 中山大学附属第七医院(深圳) | 一种吲哚丙酸在制备用于治疗自闭症药物中的应用 |
| CN115825314A (zh) * | 2021-09-17 | 2023-03-21 | 中国科学院深圳先进技术研究院 | 一种阿尔兹海默症生物标志物s-甲基-5′-硫代腺苷及其应用 |
| WO2023154547A1 (en) | 2022-02-14 | 2023-08-17 | Axial Therapeutics, Inc. | Colon targeted drug delivery |
| WO2023154966A1 (en) * | 2022-02-14 | 2023-08-17 | Axial Therapeutics, Inc. | Compositions and methods for sequestering metabolites in the gastrointestinal tract |
| CN116990395A (zh) * | 2022-04-26 | 2023-11-03 | 中国科学院深圳先进技术研究院 | 一种基于粪便的阿尔兹海默症生物标志物及其应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4761284A (en) * | 1977-12-27 | 1988-08-02 | Kureha Kagaku Kogy Kabushiki Kaisha | Antidote including activated carbon particles |
| JPS5673542A (en) * | 1979-11-22 | 1981-06-18 | Kureha Chem Ind Co Ltd | Adsorbent |
| GB9611437D0 (en) | 1995-08-03 | 1996-08-07 | Secr Defence | Biomaterial |
| US7651974B2 (en) | 2002-11-01 | 2010-01-26 | Kureha Chemical Industry Co., Ltd. | Adsorbent for oral administration |
| JP2008523100A (ja) * | 2004-12-13 | 2008-07-03 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ５ｈｔ２ｃ受容体に関連した疾患の治療に有用な５ｈｔ２ｃ受容体のモジュレータとしてのｎ−ビアリール及びｎ−アリールヘテロアリール２−置換ピペラジン誘導体 |
| SG174220A1 (en) * | 2009-03-05 | 2011-10-28 | Mithridion Inc | Compounds and compositions for cognition-enhancement, methods of making, and methods of treating |
| KR101593287B1 (ko) * | 2011-03-04 | 2016-02-11 | 가부시끼가이샤 구레하 | 정제형의 경구 투여용 조성물 및 그의 제조 방법 |
| US20140213534A1 (en) * | 2011-05-23 | 2014-07-31 | Thomas Jefferson University | Intestinal hyperpermeability and prevention of systemic disease |
| GB201204696D0 (en) * | 2012-03-16 | 2012-05-02 | Ucl Business Plc | Therapy |
| US10220089B2 (en) * | 2012-08-29 | 2019-03-05 | California Institute Of Technology | Diagnosis and treatment of autism spectrum disorder |
| TWI520751B (zh) | 2013-02-22 | 2016-02-11 | 吳羽股份有限公司 | 經口投予用吸附劑及腎疾病治療劑及肝疾病治療劑 |
| MX2016000293A (es) | 2013-07-09 | 2016-06-21 | Stemina Biomarker Discovery Inc | Biomarcadores del trastrono del espectro autista. |
| UA116567C2 (uk) * | 2013-07-23 | 2018-04-10 | Євро-Селтік С.А. | Комбінація оксикодону та налоксону для застосування в лікуванні болю у пацієнтів, які страждають від болю та захворювання, що призводить до дисбактеріозу кишечнику та/або підвищує ризик кишкової бактеріальної транслокації |
| US20150111878A1 (en) * | 2013-10-22 | 2015-04-23 | Steven Hoffman | Compositions and methods for treating intestinal hyperpermeability |
| US9763903B2 (en) * | 2013-10-22 | 2017-09-19 | Steven Hoffman | Compositions and methods for treating intestinal hyperpermeability |
| WO2015150590A1 (en) * | 2014-04-04 | 2015-10-08 | Biotechnobel Sa | Composition for prevention and/or treatment of chronic inflammation and concomitant biofilms in the gastrointestinal tract |
| EP3600349A4 (en) | 2017-03-31 | 2020-09-30 | Axial Biotherapeutics, Inc. | SELECTIVE GUT SEQUESTRATION AGENTS FOR THE TREATMENT AND PREVENTION OF AUTISM AND RELATED DISORDERS |
-
2018
- 2018-03-31 EP EP18778222.2A patent/EP3600349A4/en not_active Withdrawn
- 2018-03-31 JP JP2020502532A patent/JP6978122B2/ja not_active Expired - Fee Related
- 2018-03-31 BR BR112019020289-7A patent/BR112019020289A2/pt not_active Application Discontinuation
- 2018-03-31 AU AU2018243836A patent/AU2018243836B9/en not_active Ceased
- 2018-03-31 KR KR1020197032302A patent/KR102328323B1/ko not_active Expired - Fee Related
- 2018-03-31 CN CN201880034095.5A patent/CN110944650B/zh active Active
- 2018-03-31 CN CN202210138407.5A patent/CN114569633B/zh active Active
- 2018-03-31 CA CA3191747A patent/CA3191747A1/en active Pending
- 2018-03-31 WO PCT/US2018/025607 patent/WO2018183986A1/en not_active Ceased
- 2018-03-31 CA CA3095724A patent/CA3095724C/en active Active
- 2018-05-31 US US15/994,571 patent/US10617718B2/en active Active
-
2020
- 2020-03-23 US US16/827,629 patent/US20200390809A1/en not_active Abandoned
- 2020-06-10 US US16/898,201 patent/US11007219B2/en not_active Expired - Fee Related
-
2021
- 2021-07-22 AU AU2021206871A patent/AU2021206871B2/en not_active Ceased
-
2022
- 2022-01-14 AU AU2022200220A patent/AU2022200220A1/en not_active Abandoned
-
2023
- 2023-06-30 US US18/345,279 patent/US20230364135A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020513032A5 (enExample) | ||
| JP2018513107A5 (enExample) | ||
| RU2010121827A (ru) | Композиции для лечения болезни паркинсона | |
| JP2016535777A5 (enExample) | ||
| JP2014518275A5 (enExample) | ||
| JP2008546842A5 (enExample) | ||
| JP2014506321A5 (enExample) | ||
| JP2016199576A5 (enExample) | ||
| JP2012517987A5 (ja) | 吸入用の医薬組成物のｆｐｄ特性を設定する方法 | |
| CN109310769A (zh) | 用rxr激动剂与甲状腺激素的组合的自身免疫疾病的治疗 | |
| RU2007119721A (ru) | Частицы для лечения легочной инфекции | |
| JP2020531543A (ja) | アマンタジン組成物、その調製、および使用方法 | |
| JP2019503335A (ja) | ジメチルアミノミケリオリドの使用 | |
| Mollica et al. | Obstructive sleep apnea and cardiovascular risks in the elderly population | |
| JP4180258B2 (ja) | ＩｇＥ抗体抑制剤および食品 | |
| IL309959A (en) | Rapid relief of motor fluctuating episodes in Parkinson's disease | |
| Lemko et al. | The usage of haloaerosoltherapy in the rehabilitational treatment of children with reccurent bronchitis | |
| CN104161742A (zh) | 芬戈莫德及其结构类似物用于制备治疗脑出血药物的应用 | |
| CN105078899B (zh) | 一种恩诺沙星复层高分子矫味骨架微粒及其制备方法 | |
| JP2020509036A5 (enExample) | ||
| CN104274643B (zh) | 一种治疗小儿肺炎的中药 | |
| JP2018529747A5 (enExample) | ||
| JPWO2003022290A1 (ja) | 糖尿病性神経障害用医薬組成物 | |
| JP2021525796A (ja) | 神経疾患の阻害 | |
| RU2347576C1 (ru) | Средство для коррекции гиперреактивности дыхательных путей у детей |